Loading…
Targeted Genomics offers the GlutenID test, an FDA-cleared at-home genetic test that identifies celiac disease risk by analyzing HLA DQ2 and HLA DQ8 genotypes from a saliva sample. The test provides a gradient of genetic risk to help rule out or indicate the likelihood of celiac disease, with results designed for sharing with healthcare providers.
AI named Targeted Genomics in January 2026.